Global Penny Stocks With Market Caps Over US$900M To Watch

Global markets have recently experienced mixed performances, with technology shares rallying due to strong earnings reports and declining oil prices supporting investor sentiment. In this context, penny stocks—often smaller or newer companies—remain an intriguing area for investors willing to explore beyond established names. Despite the vintage connotation of their name, these stocks can offer surprising value and potential growth when backed by solid financials.

We'll examine a selection from our screener results.

Nickel Asia (PSE:NIKL)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Nickel Asia Corporation operates in the Philippines, focusing on mining and exploring nickel saprolite, limonite ore, limestone, and quarry materials, with a market capitalization of ₱55.72 billion.

Operations: The company's revenue is primarily derived from its mining operations, with significant contributions from Mining - TMC (₱14.97 billion), Mining - RTN (₱7.74 billion), Mining - HMC (₱4.08 billion), and Mining - CMC (₱4.60 billion), alongside its power segment, particularly Power - NEI (₱1.47 billion).

Market Cap: ₱55.72B

Nickel Asia Corporation, with a market cap of ₱55.72 billion, has demonstrated significant revenue growth, reporting ₱13.87 billion for Q2 2026 compared to ₱8.86 billion the previous year. Despite increased debt-to-equity from 7.2% to 22.5% over five years, the company maintains strong financial health with more cash than total debt and sufficient short-term assets to cover liabilities. Its Return on Equity stands at a high 22.9%, reflecting robust profitability alongside an impressive earnings growth of 228.7% in the past year, surpassing industry averages and indicating potential value for investors interested in penny stocks.

• Dive into the specifics of Nickel Asia here with our thorough balance sheet health report.
• Gain insights into Nickel Asia's future direction by reviewing our growth report.

Jointown Pharmaceutical Group (SHSE:600998)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Jointown Pharmaceutical Group Co., Ltd operates in the digital pharmaceutical distribution and supply chain sector in China, with a market cap of approximately CN¥24.68 billion.

Operations: Jointown Pharmaceutical Group Co., Ltd does not report specific revenue segments.

Market Cap: CN¥24.68B

Jointown Pharmaceutical Group Co., Ltd, with a market cap of CN¥24.68 billion, recently announced a private placement to raise up to CN¥2.8 billion through preferred shares, indicating efforts to bolster its financial position. The company reported sales of CN¥87.28 billion for H1 2026, showing growth from the previous year; however, net income declined to CN¥1.20 billion from CN¥1.45 billion. Despite negative earnings growth over the past year and declining profit margins (currently at 1.2%), it trades below estimated fair value and maintains more cash than total debt, suggesting potential resilience in the volatile penny stock market segment.

• Take a closer look at Jointown Pharmaceutical Group's potential here in our financial health report.
• Examine Jointown Pharmaceutical Group's earnings growth report to understand how analysts expect it to perform.

Chengdu Hongqi ChainLtd (SZSE:002697)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Chengdu Hongqi Chain Co., Ltd. operates convenience supermarkets in China and has a market capitalization of CN¥6.46 billion.

Operations: The company generates revenue from its retail segment, specifically through grocery stores, amounting to CN¥9.42 billion.

Market Cap: CN¥6.46B

Chengdu Hongqi Chain Co., Ltd. operates with a market cap of CN¥6.46 billion, demonstrating financial stability by being debt-free and having short-term assets (CN¥5.1 billion) that exceed both its short-term (CN¥3.1 billion) and long-term liabilities (CN¥283.5 million). Despite experiencing negative earnings growth over the past year, the company maintains high-quality earnings and trades at a significant discount to its estimated fair value, potentially offering attractive relative value in the penny stock segment. However, a new board and management team present potential risks related to experience in navigating market challenges effectively.

• Get an in-depth perspective on Chengdu Hongqi ChainLtd's performance by reading our balance sheet health report here.
• Evaluate Chengdu Hongqi ChainLtd's prospects by accessing our earnings growth report.

Key Takeaways

• Get an in-depth perspective on all 3,605 Global Penny Stocks by using our screener here.
• Searching for a Fresh Perspective? Trump has pledged to "unleash" American oil and gas and these 23 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com